SCHEMBL4182671

SCHEMBL4182671

COc1ccc2c(Cl)cc(-c3c[nH]nc3Cc3ccccc3)nc2c1C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 1/20 0.35
PDE4A P27815 3/20 0.34
PDE4B Q07343 3/20 0.34
PDE4C Q08493 3/20 0.34
PDE4D Q08499 3/20 0.34
AURKA O14965 1/20 0.34
AURKB Q96GD4 1/20 0.34
ALDH1A1 P00352 3/20 0.34
MAPT P10636 2/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
TSHR P16473 1/20 0.34
CYP2C19 P33261 1/20 0.34
PDE3B Q13370 1/20 0.34
PDE3A Q14432 1/20 0.34
KMT2A Q03164 1/20 0.34
KDM4E B2RXH2 2/20 0.33
HPGD P15428 1/20 0.33
TP53 P04637 1/20 0.33
HSP90AA1 P07900 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4178062 0.88 PDE4A (0.34) KDRPDE4APDE4BPDE4CPDE4D
SCHEMBL4185269 0.86 KDM4E (0.34) PDE4DALDH1A1MAPTKMT2AKDM4E
SCHEMBL4189834 0.84 MAPK1 (0.37) PDE4DALDH1A1MAPTTSHRKMT2A
SCHEMBL4177976 0.83 KMT2A (0.31) PDE4DKMT2AKDM4EGAAHTT
SCHEMBL4177972 0.82 SLC10A2 (0.33) PDE4DKMT2AKDM4EHSP90AA1HSP90AB1
SCHEMBL4177982 0.76 ACHE (0.40) ALDH1A1MAPTCYP2C9KDM4ETP53
SCHEMBL4182669 0.73 PGK1 (0.51) KMT2ADHODHBRD4ADORA2A
SCHEMBL4182845 0.73 MAPT (0.34) PDE4DALDH1A1MAPTTSHRKMT2A
SCHEMBL4178311 0.72 PDE10A (0.35) ALDH1A1MAPTKMT2AKDM4EHPGD
SCHEMBL4183205 0.71 KDM4E (0.33) MAPTKMT2AKDM4EHPGDPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009014730-A1 MACROCYCLIC SERINE PROTEASE INHIBITORS IDENIX PHARMACEUTICALS, INC. (US) 2009-01-29 WO disclosed